Option chain shows key data for SeaStar Medical Holding's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for SeaStar Medical Holding.

SeaStar Medical Holding (NASDAQ:ICU) Stock, Option Chain

SeaStar Medical Holding

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

movers image

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ALCE

BNOX

BURU

DGLY

IVDA

LASE

NKTX

OUST

QFIN

QUIK

REVB

SERV

SNAL

STEC

TCBP

VEEE

VTNR

WKEY

Why Serve Robotics Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Meet FLiRT And LB.1

NUWE

Nuwellis shares are trading higher Monday after the company announced Friday that the first pediatric patient has been treated with the newly launched Quelimmune therapy in a commercial setting.

Why Nuwellis Stock Is Climbing

Wall Street

Earnings

Eurozone

Commodities

Intraday Update

ALAR

KZIA

LGVN

VRPX

Nasdaq Gains 1%; LegalZoom Shares Slide

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding Corp

SeaStar Medical Holding Corporation - Warrant

ICU Medical Inc

Press Releases

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

NKF Honors SeaStar Medical, with 2025 Corporate Innovator Award

Health Care

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

General

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Aethlon Medical

Autonomix Medical

Accelerate Diagnostics, Inc. - Common Stock

Accelerate Diagnostics

Biomerica

BioSig Technologies

Co-Diagnostics

DIH Holding US, Inc. - Class A Common Stock

DIH Holding US

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

GlucoTrack

Intelligent Bio Solutions Inc. - Common Stock

Intelligent Bio Solutions

Iridex

INVO Fertility

NeuroMetrix

Nuwellis

Nexalin Technology

PAVmed

Predictive Oncology

ReShape Lifesciences, Inc. - Common Stock

Reshape Lifesciences

SINTX Technologies

Tivic Health Systems, Inc. - Common stock

Tivic Health Systems

Tenon Medical

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Beyond Air

Xylo Technologies Ltd. - American Depositary Shares

Xylo Technologies

Maxim Group

Comments

SeaStar Medical Holding

SeaStar Medical Holding (ICU) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell